Outlook Therapeutics, Inc. · NASDAQ:OTLK
Sukhtian Faisal Ghiath bought 95,398 Outlook Therapeutics, Inc. shares (Form 4)
Traded Jul 29, 2026 · Filed Jul 29, 2026
On Jul 29, 2026, Sukhtian Faisal Ghiath (Director) bought 95,398 Outlook Therapeutics, Inc. shares at US$1.05 for US$100K, leaving 220,972 shares. Filed Jul 29, 2026 (Form 4).
- Bought
- 95,398 shares
- Price
- US$1.05
- Value
- US$100K
- Holding after
- 220,972 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 29, 2026 | Common Stock | Buy | 95,398 | US$1.05 | 220,972 | Direct |
Source
Related
- Outlook Therapeutics, Inc.
- Sukhtian Faisal Ghiath
- Outlook Therapeutics, Inc. shareholders
- Form 4 · Sukhtian Faisal Ghiath · May 27, 2026
- Schedule 13G · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Kenyon Lawrence A · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026